Cargando…
Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
We previously found that age, sex, and malaria were associated with KSHV viral load in individuals from Uganda. In this study, we have evaluated factors associated with presence of EBV DNA in blood and oral fluids among the same individuals, using the same biological samples. Overall, 74% of oral fl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002824/ https://www.ncbi.nlm.nih.gov/pubmed/36909626 http://dx.doi.org/10.21203/rs.3.rs-2613771/v1 |
_version_ | 1784904468054147072 |
---|---|
author | Nalwoga, Angela Marshall, Vickie Miley, Wendell Labo, Nazzarena Whitby, Denise Newton, Robert Rochford, Rosemary |
author_facet | Nalwoga, Angela Marshall, Vickie Miley, Wendell Labo, Nazzarena Whitby, Denise Newton, Robert Rochford, Rosemary |
author_sort | Nalwoga, Angela |
collection | PubMed |
description | We previously found that age, sex, and malaria were associated with KSHV viral load in individuals from Uganda. In this study, we have evaluated factors associated with presence of EBV DNA in blood and oral fluids among the same individuals, using the same biological samples. Overall, 74% of oral fluids samples and 46% of PBMCs had detectable EBV, compared to 24% and 11% for KSHV respectively Individuals with EBV in PBMCs were more likely to have KSHV in PBMCs (P=0.016). The peak age for detection of EBV in oral fluids was 3–5 years while that of KSHV was 6–12 years. In PBMCs, the peak age for detection of EBV was 66+ years and KSHV was 3–5 years. Individuals with malaria had higher levels of EBV in PBMCs compared to malaria-negative individuals (P=0.002). In summary, our results show that younger age and malaria are associated with higher levels of EBV and KSHV in PBMCs suggesting malaria impacts immunity to EBV and KSHV. |
format | Online Article Text |
id | pubmed-10002824 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Journal Experts |
record_format | MEDLINE/PubMed |
spelling | pubmed-100028242023-03-11 Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda Nalwoga, Angela Marshall, Vickie Miley, Wendell Labo, Nazzarena Whitby, Denise Newton, Robert Rochford, Rosemary Res Sq Article We previously found that age, sex, and malaria were associated with KSHV viral load in individuals from Uganda. In this study, we have evaluated factors associated with presence of EBV DNA in blood and oral fluids among the same individuals, using the same biological samples. Overall, 74% of oral fluids samples and 46% of PBMCs had detectable EBV, compared to 24% and 11% for KSHV respectively Individuals with EBV in PBMCs were more likely to have KSHV in PBMCs (P=0.016). The peak age for detection of EBV in oral fluids was 3–5 years while that of KSHV was 6–12 years. In PBMCs, the peak age for detection of EBV was 66+ years and KSHV was 3–5 years. Individuals with malaria had higher levels of EBV in PBMCs compared to malaria-negative individuals (P=0.002). In summary, our results show that younger age and malaria are associated with higher levels of EBV and KSHV in PBMCs suggesting malaria impacts immunity to EBV and KSHV. American Journal Experts 2023-03-02 /pmc/articles/PMC10002824/ /pubmed/36909626 http://dx.doi.org/10.21203/rs.3.rs-2613771/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Article Nalwoga, Angela Marshall, Vickie Miley, Wendell Labo, Nazzarena Whitby, Denise Newton, Robert Rochford, Rosemary Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda |
title | Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda |
title_full | Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda |
title_fullStr | Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda |
title_full_unstemmed | Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda |
title_short | Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda |
title_sort | comparison of epstein-barr virus and kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of hiv-negative individuals aged 3 to 89 years from uganda |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002824/ https://www.ncbi.nlm.nih.gov/pubmed/36909626 http://dx.doi.org/10.21203/rs.3.rs-2613771/v1 |
work_keys_str_mv | AT nalwogaangela comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda AT marshallvickie comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda AT mileywendell comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda AT labonazzarena comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda AT whitbydenise comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda AT newtonrobert comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda AT rochfordrosemary comparisonofepsteinbarrvirusandkaposissarcomaassociatedherpesvirusviralloadinperipheralbloodmononuclearcellsandoralfluidsofhivnegativeindividualsaged3to89yearsfromuganda |